Junctional adhesion molecule-A, an epithelial–mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer-Reference-Cited by-同舟云学术

Junctional adhesion molecule-A, an epithelial–mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer

Published:2014-11-21 Issue:1 Volume:36 Page:41-48
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Tian Yunhong,Tian Yunming,Zhang Weijun,Wei Fang,Yang Jing,Luo Xiaojun,Zhou Tao,Hou Bing,Qian Shen,Deng Xubing,Qiu Yihan,Yao Kaitai

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/36/1/41/14133957/bgu230.pdf

Reference23 articles.

1. Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation;Liang;Am. J. Physiol. Cell Physiol.,(2000)

2. Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity;Mandell;J. Biol. Chem.,(2005)

3. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes;Ostermann;Nat. Immunol.,(2002)

4. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression;Murakami;PLoS One,(2011)

5. The role of junctional adhesion molecules in vascular inflammation;Weber;Nat. Rev. Immunol.,(2007)

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation and characterization of mAb 61H9 against junctional adhesion molecule-a with potent antitumor activity;PeerJ;2024-03-14

2. Tight Junction Protein Signaling and Cancer Biology;Cells;2023-01-06

3. Epithelial-mesenchymal transition and resistance to EGFR inhibitors;Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC;2023

4. Tight Junctions, Epithelial-Mesenchymal Transition, and Cancer Metastasis;Tight Junctions in Inflammation and Cancer;2023

5. Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia;Cancers;2022-11-15